IDEA 1.0 Course: Innovating Decisions and Empowering Action in Diabetes Management
CME Credits:
MOC Credits:



The IDEA program will improve participants' understanding of glucose monitoring, report interpretations, and the use of this information to optimize therapeutic management, leading to practice transformation and increased shared decision-making.

CME/MOC Credits

Starts 1/20/2020 | Expires 1/1/2023

Participants will be better able to:

  • Discuss the limitations of A1c as a marker of diabetes control
  • Explain the merits of evaluating time in range and hypoglycemic and hyperglycemic excursions and as well as A1c
  • Describe how glucose monitoring devices facilitate prevention, detection, and prompt treatment of hypoglycemia
  • Discuss improved patient outcomes associated with glucose monitoring as well as technological advances that have improved the ease of use of these devices

IDEA is developed in collaboration with the following organizations:

  • Association of Diabetes Care and Education Specialists (ADCES)
  • American Society of Endocrine Physician Assistants (ASEPA)
  • Diabetes Patient Advocacy Coalition
  • The Leona M. and Harry B. Helmsley Charitable Trust
  • The diaTribe Foundation - Close Concerns
  • The France Foundation (TFF)
  • American College of Clinical Pharmacy (ACCP)
  • Juvenile Diabetes Research Foundation (JDRF)
  • International Diabetes Center (IDC)
  • T1D Exchange


George Grunberger, MD, FACP, FACE

Bruce Buckingham, MD

Guillermo Umpierrez, MD, FACP, CDE, FACE

Richard M. Bergenstal, MD

Anne Peters, MD

Timothy Bailey, MD, FACE

Daniel Einhorn, MD, FACP, FACE


Lawrence Blonde, MD, FACP, MACE


Accreditation Statement


The American College of Endocrinology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Statement of Need

This unique educational initiative, IDEA, will create educational and awareness programs for both clinicians and patients. The goal of this initiative is to help the diabetes community understand continuous glucose monitoring (CGM), report interpretations, and how to use this information to optimize therapeutic management. This educational activity provides a guide for the development and distribution of teaching and learning resources to make the use of CGM Glucose Pattern Summary and Blood Glucose Pattern Summary reports best practice standards in the care of patients with diabetes.

The IDEA Project is a major educational initiative that will change the way CGM data is interpreted and used in diabetes care by health care professionals and by patients with diabetes. The project has several goals:

  • Improve the understanding of continuous glucose monitoring as well as report interpretations
  • Optimize the many facets of diabetes management including lifestyle and medication changes
  • Analyze opportunities for practice transformation, increased shared decision-making, and more personalized care

Target Audience

  • Endocrinologists
  • Primary care clinicians, including Physician Assistants and Nurse Practitioners
  • Diabetes Educators (including CDE, RN, PharmD)
  • Patients and Caregivers living with Diabetes
Disclosures/Conflict of Interest

The American Association of Clinical Endocrinology (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.

Faculty Disclosures

Name of Individual with Disclosed Financial RelationshipRole of this Individual in the ActivityName of Commercial Interest Disclosed
George Grunberger, MD, FACP, FACEContent AuthorNovo Nordisk, Honorarium
Bruce Buckingham, MDContent AuthorConvatec, Honorarium, Research Support
Dexcom, Research Support
Tandem, Research Support
Insulet, Honorarium, Research Support
Medtronic, Honorarium, Research Support
Guillermo Umpierrez, MD, FACP, CDE, FACEContent AuthorMerck, Grant Support
Richard M. Bergenstal, MDContent AuthorAbbott Diabetes Care, Consulting, Grant funding with employer
Ondu, Grant funding with employer
Boehringer Ingelheim, Grant funding with employer
United Health Group, Grant funding with employer
DexCom, Grant funding with employer
Hygieia, Grant funding with employer
Johnson & Johnson, Grant funding with employer
Medtronic, Grant funding with employer
Merck, Grant funding with employer
Novo Nordisk, Grant funding with employer
Roche, Grant funding with employer
Sanofi, Grant funding with employer
Anne Peters, MDContent Author01/25/2019
Timothy Bailey, MD, FACEContent AuthorResearch Support - Abbott, Ascensia, BD, Boehringer Ingelheim, Calibra Medical, Companion Medical, Dance Biopharm, Dexcom, Eli Lilly, Glysens, Kowa, Lexicon, Medtronic, Novo Nordisk, POPS! Diabetes Care, Sanofi, Senseonics, Taidoc, Xeris
Consulting Honoraria - Abbott, Capillary Biomedical, Eli Lilly, Medtronic, Novo Nordisk, Sanofi
Speaking Honoraria - Abbott, MannKind, Medtronic, Novo Nordisk, Sanofi, Senseonics
Daniel Einhorn, MD, FACP, FACEContent AuthorHalozyme, Honorarium
Novo Nordisk, Honorarium
Ji Chun, PA-C, MPAS, BC-ADMContent AuthorAstra Zeneca, Honorarium
Sanofi, Honorarium
Merck, Honorarium
Mannkind, Honorarium
Corcept, Honorarium
Lawrence Blonde, MD, FACP, MACEContent AuthorEli Lilly and Company, Grant Research Support
Novo Nordisk, Grant Research Support, Honorarium Speaker, Consultant
Sanofi, Grant Research Support, Honorarium Speaker, Consultant
Janssen Pharmaceuticals, Inc., Honorarium
GlaxoSmithKline, Honorarium
Merck & Co., Honorarium Speaker, Consultant, Grant/Research Support
Lexicon Pharmaceuticals, Inc., Grant/Research Support
Intarcia Therapeutics, Inc., Honorarium, Consultant
Gilead Sciences, inc., Honorarium
Ji Hyun Chun, MPAS, PA-C, BC-ADMPlannerAstraZeneca, Intarcia, Mannkind, Merck & Co., Inc, Novo Nordisk
Christel Aprigliano, MSPlannerInsulet
Christina RothPlannerThe College Diabetes Network Inc.
Gregg Simonson, PhDPlannerAbbott, Merck & Co., Inc.
Theodore Bruno, MDPlannerAllergen
Shelly EndersPlannerSanofi
Dana GershenoffPlannerMedtronic Educator Advisory Board


Commercial Support

Commercial Support

This activity is supported by independent educational grants from Abbott Diabetes Care, AstraZeneca, Dexcom, Inc., Janssen Pharmaceuticals, Inc., Mannkind Corporation, and Novo Nordisk Inc.


Copyright 2019, AACE. All rights reserved. No part of this enduring material may be reproduced or transmitted in any other form or by any other means, electronic or mechanical, without first obtaining written permission from AACE.